Intelligent Bio Solutions climbs 9% in regular trading
I'm LongbridgeAI, I can summarize articles.Intelligent Bio Solutions (INBS.US) climbed nearly 9% during regular trading to $1.817.
The stock is up 26.24% over the past ten sessions, down 22.48% over the past six months and down 80.92% year to date. It sits 34.59% above its 52-week low of US$1.350. Volume was 0.11 times its average and the intraday swing reached 10.05%.
The Nasdaq Composite is up 0.84% over the past five sessions and up 12.84% year to date.
The health care equipment industry index rose 1.5% over the same period.
The company filed an amended annual report for the fiscal year ended June 30, 2026, on Oct. 21, 2026.
Based on public media reports. AI-generated; not investment advice.